DNA Capital is a healthcare investment firm based in São Paulo, Brazil, and San Francisco, California. It focuses on multi-stage investments in healthcare companies across Latin America and North America.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
DNA Capital is a healthcare investment firm founded in 2013 by Pedro Bueno, with offices in São Paulo, Brazil, and San Francisco, California. The firm specializes in multi-stage investments in the healthcare sector, targeting companies at early, growth, and late stages. DNA Capital emphasizes high-quality, ethical, and humane products and services, leveraging its extensive network and operational expertise to support exceptional founders and management teams. With a total platform AUM of approximately $3.5 billion, DNA Capital is recognized as one of the most capitalized healthcare-dedicated investors in Latin America, with a portfolio that includes notable companies such as DASA, Alto Pharmacy, and Clover Health.
DNA Capital invests exclusively in the healthcare sector, providing capital and support to companies at all stages, from early-stage venture capital to late-stage private equity. The firm operates globally, with a strong emphasis on Latin America, particularly Brazil, and seeks to connect, accelerate, and optimize healthcare businesses.
DNA Capital adds value to its portfolio companies through operating leverage derived from its extensive network in the healthcare sector, including access to hospitals, diagnostics, and pharmaceutical distribution. This strategic advantage allows the firm to support its companies effectively in scaling and optimizing their operations.
DNA Capital invests exclusively in the healthcare sector, focusing on companies at various stages, including pre-seed, seed, Series A, and growth equity. The firm emphasizes ethical and humane products and services, seeking high-quality investments that align with its values.
Founders can pitch DNA Capital through their website at dnacapital.com/contact or via email at contact@dnacapital.com. It is advisable to include a detailed business plan and financial projections in the pitch.
DNA Capital's exclusive focus on healthcare and its deep connections within the industry, particularly through the Bueno family's strategic holdings, provide unique insights and resources that enhance the growth potential of portfolio companies.
The firm operates globally, with a particular emphasis on North America and Latin America. This geographic focus allows DNA Capital to tap into diverse healthcare markets and opportunities.
While specific check sizes are not disclosed, DNA Capital invests across multiple stages, indicating a range of investment amounts from early-stage funding to larger growth equity rounds.
DNA Capital adds value through its extensive network and operational expertise, leveraging the Bueno family's strategic holdings in healthcare to provide unique insights and access to resources that enhance growth and scalability.
Organizations that do similar work to DNA Capital.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorOrbiMed is a healthcare-focused investment firm based in New York City, managing approximately $19 billion in assets. The firm invests across the healthcare spectrum, from early-stage startups to large multinational companies, with a focus on biopharmaceuticals and medical technologies.
InvestorEmpowering innovation through strategic investments.
Superscout Pro
Is this page right?Reviewed · How the research works